Dr. Filbin has expertise in management of septic shock in the emergency department, with a particular interest in early identification. In collaboration with critical care investigators both locally and nationally, he has conducted NIH- and industry-funded clinical trials in septic shock. Dr. Filbin has recently co-authored the largest prospective clinical trial to date investigating the merits of goal-directed therapy for patients with septic shock (The ProCESS Investigators. A Randomized Trial of Protocol-Based Care for Early Septic Shock. New England Journal of Medicine: Epub ahead of print March 18, 2014).